Healthcare Tracked since Q3 FY26 - Q3 FY26

Lincoln Pharmaceuticals Ltd

LINCOLNPHARMACEUTICALS

Latest quarter Q3 FY26

Revenue ₹166 Cr (+13.5% YoY)

Management credibility Building

Needs more scored promises across 1 quarters

Latest signal bullish

Lincoln Pharma delivered a solid Q3 FY26 with revenue of ₹166.3 Cr (+13.5% YoY) and PAT of ₹28.6 Cr (+37.7% YoY), dri...

Quarterly Earnings Timeline

Filing-verified financials, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q3 FY26 15 Feb 2026

bullish medium

Revenue ₹166 Cr (+13.5% YoY)

Lincoln Pharma delivered a solid Q3 FY26 with revenue of ₹166.3 Cr (+13.5% YoY) and PAT of ₹28.6 Cr (+37.7% YoY), driven by strong export growth and the new cephalospo...

Scorecard starts after historical backfill Read full analysis →